Mylan Names Ranjan Ray Chaudhuri As Global Commercial Lead For OTC Business

(RTTNews) - Mylan N.V. (MYL), a pharmaceutical company, Friday announced the appointment of Ranjan Ray Chaudhuri to serve as global commercial lead of the company's over-the-counter business. Chaudhuri will report to Rajiv Malik, president of Mylan.

Chaudhuri joins Mylan from GlaxoSmithKline Consumer Healthcare, where he served for nearly three decades. During his time at GSK, Chaudhuri was responsible for the company's global smoking reduction and cessation category, which included NiQuitin and other well-known nicotine replacement therapies or NRTs.

Working in close partnership with market leaders, he turned around the business' performance, and delivered double-digit revenue growth.

Chaudhuri also led the development of an innovative program designed to improve the quality of life of COPD patients by leveraging NRTs along with other GSK respiratory products, such as Advair and Seretide.

Prior to that, Chaudhuri served as innovation director for GSK's Smoking Control and Cold Sore franchises, driving double-digit sales growth in the latter through product launches and creative advertising.